Piramal to acquire drugs from UK's Mallinckrodt for Rs 1,162 crore
Piramal Enterprises on Monday said it will acquire a portfolio of intrathecal spasticity and pain management drugs from UK-based Mallinckrodt for USD 171 million (around Rs 1,162 crore) in an all cash deal.
Jan 30, 2017, 14:08 PM IST